Project Name：Roflumilast and preparations 

Registration Classification：3.1

Formulations and specifications ：Tablets, 500mg 

Indications：Severe chronic obstructive pulmonary disease (COPD) (FEV1 <50% predicted value after bronchodilator use ) maintenance therapy .

Original Research Company：Germany Altana 

Progress ：Pharmaceutical Research in progress